Komodo Drug Projections

Komodo Drug Projections is a software solution within the Komodo Health platform designed to deliver high-quality, accurate drug market projections for life sciences commercial teams. By combining multiple distinct views of the U.S. healthcare system, it provides weekly national and subnational projections for both pharmacy-benefit (Rx) and medical-benefit (Mx) drugs, offering visibility down to the individual account, HCP/HCO, and zip code levels. It is built for commercial strategists, data analysts, and market intelligence teams who need reliable, transparent data to inform revenue forecasting, market share analysis, marketing ROI, and salesforce sizing.

Unlike black-box methodologies, Komodo Drug Projections presents observed and projected data side by side with confidence intervals, enabling teams to trust and interrogate the underlying insights. The tool is part of the broader Komodo Software Suite and is powered by the Healthcare Map, the industry's most comprehensive source of deidentified patient-level data.

Core Pillars of the Projections Model

• The Healthcare Map: The data foundation underpinning all projections is built on years of curating, acquiring, and transforming multiple datasets. It provides the most comprehensive and accurate view of total dispenses for any market basket of drugs across the U.S. healthcare system.
• Data Provider Diversity: Projections leverage the unique characteristics of both payer-derived and provider-derived data, as well as their intersection. These datasets cover the full patient journey and provide visibility into nearly every provider in the U.S. healthcare system, offering insights into subset populations through a wide range of events.
• Multiple Statistical Methods: The model calculates probability estimates of coverage for individual drugs and continuously incorporates learnings as new data is ingested. It monitors the consistency of a product's payer and provider mix over time and adjusts to account for trend breaks and other market disruptions.

Key Features and Capabilities

• Track Market Share Across Multiple Drugs: Identify opportunities faster with key insights into complex market baskets where therapies compete across Rx and Mx benefits. Prioritize areas of focus, identify competitive opportunities for maximum impact, and gain a deeper understanding of peak market share dynamics.
• Visualize Projected and Observed Insights Together: Compare total observed versus projected values in a single, unified dashboard for a holistic view of your market basket. Use confidence intervals to inform scenario models and sensitivity analyses, and utilize weekly projection factors to account for natural data lags.
• Trend Multiple Drugs to Understand the Market: Track performance in real time with detailed competitive market share insights at both the drug and molecule level, including Rx and Mx classifications. Gain visibility from the subnational level down to individual HCP and HCO levels, and track hard-to-project specialty and medical benefit drugs for stakeholder reporting.
• Analyst Empowerment: Enable analysts to fine-tune their own proprietary models using weekly projection factors, supporting more accurate and customized internal forecasting workflows.

Use Cases and Business Applications

• Revenue forecasting and market share analysis across competitive drug landscapes
• Marketing ROI measurement and salesforce sizing decisions
• Real-time competitive intelligence for commercial strategy teams
• Scenario modeling and sensitivity analyses using confidence interval data
• Stakeholder reporting on specialty and medical benefit drug performance

Komodo Drug Projections is delivered as part of the Komodo Health Software Suite and integrates with the broader Healthcare Map ecosystem, including MapLab and other analytics tools. It is designed for life sciences organizations — including commercial, HEOR/RWE, and medical affairs teams — seeking a transparent, trustworthy alternative to opaque projection methodologies.